Status:
COMPLETED
Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake
Lead Sponsor:
Gunma University
Collaborating Sponsors:
J~pharma
Conditions:
Angiogenesis
Non-Small Cell Lung Cancer
Eligibility:
All Genders
Brief Summary
Purpose: L-\[3-18F\]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for PET. We have conducted a clinicopathologic study to elucidate the correlation of angiogenesis with 18F-FMT and 18F-FDG uptak...
Eligibility Criteria
Inclusion
- Patients who underwent a thoracotomy within 4 weeks after 18F-FMT PET and 18F-FDG PET study
- Histology is non-small cell lung cancer
Exclusion
- Patient who received neoadjuvant chemotherapy or radiotherapy before surgery
- Patients who have insulin-dependent diabetes
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00671242
Last Update
May 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gunma University Graduate School of Medicine
Showa-machi, Maebashi, Gunma, Japan, 371-8511